最新报道:Semler Scientific's stock plunged 18% after announcing plans to adopt Bitcoin as its primary treasury reserve asset, purchasing 581 BTC for $40 million. The medical device maker's pivot to crypto sparked investor concerns, overshadowing its Q1 revenue growth to $15.9 million. CEO Doug Murphy-Chutorian defended the strategy, citing Bitcoin's potential as "an attractive investment" and "a reasonable hedge against inflation." The company will continue holding Bitcoin on its balance sheet while maintaining cash reserves for operations. This move follows MicroStrategy's playbook of corporate Bitcoin adoption, though markets reacted negatively to the unexpected treasury shift from the traditionally conservative healthcare sector.